Science Explorer Back to mapMap

Most cited papers from Centro di Riferimento Oncologico

What are the most cited papers from Centro di Riferimento Oncologico?

The most cited paper from Centro di Riferimento Oncologico is "Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial" (Rafael Rosell et al., 2012), with 5,563 citations. Next come "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (2,743) and "The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine" (2,014).

Showing 50 of 60 papers. Every paper with more than 450 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial Rafael Rosell et al. · The Lancet Oncology Open access 30 Jan 2012 5,563
2 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
3 The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine Samer Bayda, Muhammad Adeel, Tiziano Tuccinardi et al. · Molecules Open access 27 Dec 2019 2,014
4 Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication Raffaella Di Micco, Marzia Fumagalli, Angelo Cicalese et al. · Nature Nov 2006 1,835
5 Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology Open access 28 Mar 2018 1,636
6 A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 Rayjean J. Hung et al. · Nature Open access Apr 2008 1,296
7 Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium Mia Hashibe et al. · Cancer Epidemiology Biomarkers & Prevention Open access Feb 2009 1,270
8 Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial Viviana Enrica Galimberti et al. · The Lancet Oncology Open access 10 Mar 2013 1,247
9 Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis Salvatore Vaccarella, Silvia Franceschi, Freddie Bray et al. · New England Journal of Medicine 17 Aug 2016 1,159
10 Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium Mia Hashibe et al. · JNCI Journal of the National Cancer Institute Open access 15 May 2007 1,116
11 Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer Fotios Loupakis, Chiara Cremolini, Gianluca Masi et al. · New England Journal of Medicine Open access 22 Oct 2014 1,097
12 Long non-coding RNAs and cancer: a new frontier of translational research? Riccardo Spizzo, Maria Inês Almeida, Alfonso Colombatti et al. · Oncogene Open access 23 Jan 2012 1,074
13 Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Alessandro Gronchi et al. · Annals of Oncology Open access 22 Jul 2021 1,057
14 Brigatinib versus Crizotinib in ALK -Positive Non–Small-Cell Lung Cancer D. Ross Camidge et al. · New England Journal of Medicine Open access 25 Sep 2018 997
15 High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients Mariantonia Logozzi, Angelo De Milito, Luana Lugini et al. · PLoS ONE Open access 16 Apr 2009 971
16 Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Alberto P. Avolio, S G Chen, R P Wang et al. · Circulation Jul 1983 968
17 Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy Gary M. Clifford, Jerry Polesel, Martin Rickenbach et al. · JNCI Journal of the National Cancer Institute 15 Mar 2005 863
18 Influence of processing on the antioxidant properties of fruit and vegetables Maria Cristina Nicoli, Monica Anese, Maria Teresa Parpinel · Trends in Food Science & Technology Mar 1999 847
19 Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Alberto P. Avolio, Furong Deng, W.Q. Li et al. · Circulation Open access Feb 1985 842
20 E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer Fabio Petrocca, Rosa Visone, Mariadele Rapazzotti Onelli et al. · Cancer Cell Open access Mar 2008 836
21 Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial Jayant Sharad Vaidya et al. · The Lancet Open access 10 Nov 2013 834
22 Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial Antonio Palumbo et al. · The Lancet Mar 2006 811
23 Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial Jayant Sharad Vaidya et al. · The Lancet Open access 8 Jun 2010 770
24 Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology Open access 28 Mar 2018 759
25 Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer Olivia Pagani et al. · New England Journal of Medicine Open access Jun 2014 756
26 Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection Giacomo Spinato, Cristoforo Fabbris, Jerry Polesel et al. · JAMA Open access 22 Apr 2020 745
27 MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer Mattia Boeri, Carla Verri, Davide Conte et al. · Proceedings of the National Academy of Sciences Open access 7 Feb 2011 731
28 Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis Marco Chilosi, Venerino E. Poletti, Alberto Zamò et al. · American Journal Of Pathology Open access May 2003 720
29 Adjuvant Chemotherapy for Adult Soft Tissue Sarcomas of the Extremities and Girdles: Results of the Italian Randomized Cooperative Trial Sergio Frustaci, Franco Gherlinzoni, Antonino De Paoli et al. · Journal of Clinical Oncology Mar 2001 713
30 Induction of EMT by Twist Proteins as a Collateral Effect of Tumor-Promoting Inactivation of Premature Senescence Stéphane Ansieau, Jérémy Bastid, Agnès Doreau et al. · Cancer Cell Open access Jul 2008 706
31 Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology Open access 2 Aug 2018 655
32 A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity James D. Hudson, Mahmood A. Shoaibi, Roberta Maestro et al. · The Journal of Experimental Medicine Open access 15 Nov 1999 653
33 Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium Karin Ekstrom Ekstroem Smedby et al. · Blood Open access 8 Feb 2008 632
34 Thyroid cancer incidence trends by histology in 25 countries: a population-based study Adalberto Miranda‐Filho, Joannie Lortet‐Tieulent, Freddie Bray et al. · The Lancet Diabetes & Endocrinology Mar 2021 625
35 A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms Philipp Harter et al. · New England Journal of Medicine Open access 27 Feb 2019 616
36 Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial Luca Gianni et al. · The Lancet Oncology 26 Feb 2011 614
37 Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation Giulia Fabbri et al. · The Journal of Experimental Medicine Open access 13 Jun 2011 609
38 Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo Giovanni Casali et al. · Annals of Oncology Open access 21 Sep 2021 608
39 Machine and deep learning methods for radiomics Michele Avanzo, Lise Wei, Joseph Stancanello et al. · Medical Physics Open access May 2020 607
40 Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy. Silvia Franceschi, Renato Talamini, SALVATORE ALESSANDRO BARRA et al. · PubMed 15 Oct 1990 592
41 Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial Viviana Enrica Galimberti et al. · The Lancet Oncology 202 authors 5 Sep 2018 589
42 Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial Alice Tsang Shaw, Tae Min Kim, Lucio Crinò et al. · The Lancet Oncology 10 Jun 2017 585
43 A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study Jesse Joachim Swen et al. · The Lancet Open access257 authors Feb 2023 564
44 Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas Andrés J.M. Ferreri, Massimo Guidoboni, Maurilio Ponzoni et al. · JNCI Journal of the National Cancer Institute 20 Apr 2004 562
45 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer Australian Cancer Study et al. · Nature Genetics Open access443 authors 27 Mar 2013 544
46 Overexpression of folate binding protein in ovarian cancers Giuseppe Toffoli, Claudia Cernigoi, Antonio Giampiero Russo et al. · International Journal of Cancer Open access 22 Apr 1997 526
47 Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer Timothy R. Rebbeck et al. · JAMA Open access258 authors 7 Apr 2015 517
48 twist is a potential oncogene that inhibits apoptosis Roberta Maestro, Angelo Paolo Dei Tos, Yasuo Hamamori et al. · Genes & Development Open access Sep 1999 516
49 GSK-3 as potential target for therapeutic intervention in cancer James Andrew McCubrey, Linda S. Steelman, Fred E. Bertrand et al. · Oncotarget Open access 28 May 2014 515
50 Beyond imaging: The promise of radiomics Michele Avanzo, Joseph Stancanello, Issam El Naqa · Physica Medica Jun 2017 499

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.